This company listing is no longer active
Resumen acción IQMD
Intelligent Medicine Acquisition Corp. does not have significant operations.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Competidores de Intelligent Medicine Acquisition Corp.
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | US$11.04 |
52 Week High | US$11.22 |
52 Week Low | US$9.97 |
Beta | 0 |
1 Month Change | 7.39% |
3 Month Change | 6.87% |
1 Year Change | 10.40% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 11.97% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
IQMD | US Capital Markets | Mercado US | |
---|---|---|---|
7D | 8.1% | -3.8% | -1.7% |
1Y | 10.4% | 24.3% | 22.4% |
Rentabilidad vs. Industria: IQMD exceeded the US Capital Markets industry which returned -6.9% over the past year.
Rentabilidad vs. Mercado: IQMD exceeded the US Market which returned -5.3% over the past year.
Volatilidad de los precios
IQMD volatility | |
---|---|
IQMD Average Weekly Movement | 2.9% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: IQMD has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: IQMD's weekly volatility (3%) has been stable over the past year.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
2021 | n/a | Greg Simon | iqmdspac.com/home/default.aspx |
Resumen de fundamentos de Intelligent Medicine Acquisition Corp.
Estadísticas fundamentales de IQMD | |
---|---|
Capitalización bursátil | US$64.75m |
Beneficios(TTM) | US$11.41m |
Ingresos (TTM) | n/a |
5.7x
Ratio precio-beneficio (PE)0.0x
Ratio precio-ventas (PS)¿Está IQMD sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de IQMD | |
---|---|
Ingresos | US$0 |
Coste de los ingresos | US$0 |
Beneficio bruto | US$0 |
Otros gastos | -US$11.41m |
Beneficios | US$11.41m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | 1.95 |
Margen bruto | 0.00% |
Margen de beneficio neto | 0.00% |
Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado IQMD a largo plazo?
Ver rendimiento histórico y comparativa